Global Acne Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
Market Overview:
The latest research study on the global Acne market finds that the global Acne market reached a value of USD 5908.19 million in 2022. It’s expected that the market will achieve USD 8853.0 million by 2028, exhibiting a CAGR of 6.97% during the forecast period.
Region Overview:Geographically, North America held the largest market share – 34.67% in 2022.
Key Companies in the global Acne market covered in Chapter 3:Sun Pharmaceutical Industries Limited
Prestium Pharma Inc.
Teva Pharmaceutical Industries Ltd.
Allergan plc
Oculus Innovative Sciences
Anterios Inc.
Medicis Pharmaceutical Corporation
Daiichi Sankyo Company Ltd
GlaxoSmithKline Plc.
Valeant Pharmaceutical International Inc.
Guthy-Renker LLC
Mayne Pharma Group Limited
Bayer AG
Cipher
Foamix Pharmaceuticals
Ranbaxy Laboratories Limited
BioPharmX, Inc.
Johnson & Johnson Services Inc.
Skinvisible Pharmaceuticals
Stiefel Laboratories Inc.
Mylan N.V.
Roche Holding AG
F. Hoffmann-la Roche Ltd
Pfizer Inc.
Galderma S.A.
Aqua Pharmaceuticals
AndroScience
In Chapter 4 and Chapter 14.2, on the basis of types, the Acne market from 2018 to 2029 is primarily split into:Inflammatory Acne
Non-Inflammatory Acne
In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Acne market from 2018 to 2029 covers:Hospitals & Clinics
Pharmacies & Drug Stores
Ambulatory Surgical Centres
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)